Back To Search Results

Clin Assoc Prof George Goh Boon Bee

MBBS, MRCP (UK), M Med (Int Med), FAMS (Singapore)

Senior Consultant

Specialty: Gastroenterology ＆ Hepatology

Sub-specialties: Hepatology, Non-alcoholic Fatty Liver Disease, Viral Hepatitis, Liver Cirrhosis, Liver Transplantation, Diagnostic and Therapeutic Endoscopy

Conditions Treated by this Doctor:
Alcoholic Liver Disease, Autoimmune Hepatitis, Cirrhosis, Colorectal Cancer Screening, Fatty Liver Diseases, Functional Dyspepsia, Gastroesophageal Reflux (GER) and Gastroesophageal Reflux Disease (GERD), Hepatitis B, Hepatitis C, Irritable Bowel Syndrome, Liver Cancer, Liver Cancer (Hepatocellular Carcinoma), Liver Failure, Liver Fibrosis, Liver Transplant, Non-alcoholic Fatty Liver Disease (NAFLD), Non-alcoholic Steatohepatitis (NASH), Reflux/Gastro Oesophageal Reflux, Viral Hepatitis.

Clinical Appointments

Senior Consultant Gastroenterology ＆ Hepatology Singapore General Hospital

Academic Appointments

Clinical Associate Professor, Duke-NUS Graduate Medical School
Clinical Lecturer, Yong Loo Lin School of Medicine
Clinical Teacher, Lee Kong Chian School of Medicine

Profile

Dr. George Goh is a Senior Consultant Gastroenterologist and Hepatologist at the Singapore General Hospital. After Gastroenterology specialist training at Singapore General Hospital, he underwent further advanced subspecialty training in Hepatology at the Cleveland Clinic (USA), with a research focus on non-alcoholic fatty liver disease (NAFLD). He returned to establish a dedicated Metabolic Liver Clinic with multi-disciplinary involvement that helps to identify, prognosticate and manage patients with severe NAFLD. In addition, he remains actively involved in research and is the local Principal Investigator of several ongoing international NAFLD trials. He has published in the fields of NAFLD, liver cirrhosis, hepatocellular carcinoma and organ transplantation, and has been an invited faculty at both local and international conferences.

Dr Goh is an appointed Clinical Associate Professor at Duke-NUS Medical School and Clinical Lecturer at Yong Loo Lin School of Medicine, National University of Singapore. He is the current Chairman of the National Foundation of Digestive Disease (NFDD), which aims to increase awareness of such diseases among the general public.

Education

MBBS
MRCP (UK)
M Med (Int Med)
FAMS (Singapore)

Professional Appointments and Committee Memberships

Clinical Associate Professor, Duke-NUS Medical School
Clinical Lecturer, NUS Yong Loo Lin School of Medicine
Fellow of Academy of Medicine, Singapore (FAMS)
Member, American Association for the Study of Liver Disease (AASLD)
Chairperson, Executive committee, National Foundation of Digestive Diseases, Singapore

Awards

Gold Award Singapore Health Quality Service Awards 2017
SingHealth Publish awards 2016
AASLD 2016 Poster of distinction
Service with a Heart award November 2015
SingHealth Publish awards (Outstanding) 2015
Human Manpower Development Plan (HMDP) Fellowship Award 2013: Cleveland Clinic
Singapore Health Quality Service Award 2011- 2012: Gold
Service with a Heart award March 2012
SingHealth 2012 Best registrar award
SingHealth 2011 Best registrar award
AASLD 2010 Poster of distinction
APDW 2009 Travel award

Research Interests

Publications

PE Chang, BBG Goh, V Ekstrom, ML Ong, CK Tan. Low serum albumin predicts early mortality in patients with severe hypoxic hepatitis. World Journal of Hepatology 2017;9(22):959-966.
JW Li, GBB Goh, PE Chang, CK Tan. BCLC Outperforms HKLC Staging of Hepatocellular Carcinoma in Multiethnic Asians – Real-World Perspective. World Journal Gastroenterology 2017;23(22): 4054-63
BBG Goh, JW Li, PE Chang, CY Lin, KY Chow, CK Tan. Deciphering the epidemiology of hepatocellular carcinoma through the passage of time; a study of 1401 patients across three decades. Hepatology Communications 2017;1 (6): 564-71.
MC Cheah, AJ McCullough, GBB Goh. Current modalities of fibrosis assessment in Non-Alcoholic Fatty Liver Disease. Journal of Clinical and Translational Hepatology 2017; 5(3):1-11.
T Singh, G Kochhar, GBB Goh, P Schauer, S Brethauer, M Kroh, A Aminian, R Lopez, S Dasarathy, A McCullough.Safety and Efficacy of Bariatric Surgery in Patients with Advanced Fibrosis. International Journal of Obesity 2017 Mar; 41(3):443-449.
GBB Goh, P An, WC Chow, JM Yuan, WP Koh. Association between diabetes mellitus and cirrhosis mortality: The Singapore Chinese Health Study. Liv Int 2017 Feb;37(2):251-258
Salazar E, Tan CK, Goh BB. “Broken Heart” in Acute on Chronic Liver Failure: Case report. Proceedings of Singapore Healthcare 2016;1-2 (DOI: 10.1177/2010105816667366)
JH Ngu, GBB Goh, ZX Poh, R Soetikno. Managing Non Alcoholic Fatty Liver Disease. SMJ 2016 57(7):1-4.
J Chang, Goh BB, Tan CK. Low serum albumin and advanced age predict early mortality in Asian patients with extreme elevations of serum aminotransferases. J Dig Dis 2016 17(3): 193-201.
GBB Goh, AJ McCullough. The Natural History of NAFLD. Dig Dis Sci 2016 61(5): 1226-33.
Z Poh, L Shen, HI Yang, W Seto, VW Wong, CY Lin, BBG Goh, PE Chang, H Chan, Man-FY, CJ Chen, CK Tan. Real World Risk Score for Hepatocellular Carcinoma (RWS-HCC): a clinically practical risk predictor for HCC in chronic hepatitis B. Gut 2016 65(5): 887-8.
R Kumar & GBB Goh. Chronic hepatitis B and Fatty liver-issues in clinical management. Clinics and Research in Hepatology & Gastroenterology 2016 2016 Dec;40(6):755-759
GBB Goh, D Issa, Pagadala MR, Dasarathy J, Unalp-Arida A, Sargent R, Hawkins C, Sourianarayanane A, Khiyami A, Yerian L, Pai R, Dasarathy S., Naim Alkhouri, McCullough AJ. The Development of a Non-invasive Model to Predict the Presence of Nonalcoholic Steatohepatitis. Jou Gastro Hep 2016 31(5): 995-1000.
WP Koh, YY Dan, GBB Goh, A Jin, R Wang, JM Yuan. Dietary fatty acids and risk of hepatocellular carcinoma in the Singapore Chinese Health Study. Liver Int 2016 36 (6):893-901.
PE CHANG, GBB GOH, JH NGU, HK TAN, CK TAN. Clinical applications, limitations and future role of transient elastography in the management of liver disease. World J Gastrointest Pharmacol Ther. 2016 Feb 6;7(1):91-106
GBB GOH, PE CHANG, CK TAN. Changing epidemiology of hepatocellular carcinoma in Asia. Best Pract Res Clin Gastroenterol. 2015 Dec; 29(6):919-28.
GBB Goh, C Kwan, SY Lim, NKK Venkatanarasimha, R Abu Bakar, TL Krishnamoorthy, HH Shim, KH Tay, WC Chow. Perceptions of Non Alcoholic Fatty Liver Disease – An Asian Community Based Study. Gastroenterology Reports 2016 4(2): 131-5.
Poh ZX, Goh GB, Chang PJ, Tan CK. Rates of cirrhosis and hepatocellular carcinoma in chronic hepatitis B and the role of surveillance in a 10 year follow-up of 673 patients. Eur Jou Gastro Hep. 2015 Jun;27(6):638-43
GBB Goh, Pagadala MR, Dasarathy J, Unalp-Arida A, Sargent R, Hawkins C, Sourianarayanane A, Khiyami A, Yerian L, Pai R, Dasarathy S.,McCullough AJ. Age impacts ability of aspartate-alanine aminotransferase ratio to predict advanced fibrosis in non-alcoholic fatty liver disease. Dig Dis Sci. 2015 Jun;60(6):1825-31
GBB Goh, Pagadala MR, Dasarathy J, Unalp-Arida A, Sargent R, Hawkins C, Sourianarayanane A, Khiyami A, Yerian L, Pai R, Dasarathy S.,McCullough AJ. Clinical spectrum of Non-Alcoholic Fatty Liver Disease in diabetic and non-diabetic patients. Biochimica et Biophysica Acta (BBA) Clinical 2015;3:141-145
Hawkins C, Sourianarayanane A, Khiyami A, Yerian L, Pai R, McCullough AJ, Dasarathy S. Renin-angiotensin system and fibrosis in non-alcoholic fatty liver disease. Liver Int. 2015;35(3):979-85.
GBB Goh, WC Chow, RW Wang, JM Yuan, WP Koh. Coffee, Alcohol, and Other Beverages in Relation to Cirrhosis Mortality: The Singapore Chinese Health Study. Hepatology 2014; 60(2):661-669.
GBB Goh , ZW Mok, ZR Mok, JP Chang, CK Tan. Organ donation: what else can be done besides legislature? Clin Transplant.2013 Nov-Dec; 27(6):E659-64. doi: 10.1111/ctr.12244.
BBG Goh, DMY Tan, KL Ling. Knowledge and Attitudes of Junior Medical Doctors towards Gastric Cancer. Proceedings of Singapore Healthcare 2012; 21(3)2: 161-166.